HomeHealthStem Cell therapy safe after a spinal cord injury: Study

Stem Cell therapy safe after a spinal cord injury: Study

Stem Cell therapy safe after a spinal cord injury: Study

New York, April 1 (IANS) Stem cell therapy can be a safe option for people suffering from hard-to-treat traumatic spinal cord injuries, according to results of a phase 1 clinical trial revealed on Monday.

The trial, published by the Mayo Clinic in the US, showed that stem cells that are derived from a patient’s own fat are safe and may help in improving sensation and movement for people living with spinal cord injuries and paralysis.

“This study documents the safety and potential benefit of stem cells and regenerative medicine,” said Mohamad Bydon, a neurosurgeon at Mayo Clinic.

The study, appearing in the journal Nature Communications, included 10 adults. Of these, seven demonstrated improvements like “increased sensation when tested with pinprick and light touch, increased strength in muscle motor groups, and recovery of voluntary anal contraction, which aids in bowel function.”

While the remaining three patients showed no improvement, it did not get worse, the trial showed. No serious adverse events were recorded after the treatment, and the most commonly reported side effects were headache and musculoskeletal pain that resolved with over-the-counter treatment.

Even as the spinal cord has limited ability to repair its cells or make new ones, “even a mild improvement can make a significant difference in that patient’s quality of life,” Dr. Bydon said.

The World Health Organization (WHO) estimates that between 250,000 and 500,000 people worldwide suffer a spinal cord injury each year. However, options to improve the condition are extremely limited.

“For years, treatment of spinal cord injury has been limited to supportive care, more specifically stabilisation surgery and physical therapy,” Dr. Bydon said.

“Spinal cord injury is a complex condition. Future research may show whether stem cells in combination with other therapies could be part of a new paradigm of treatment to improve outcomes for patients,” he added.

–IANS

rvt/dan

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

RELATED ARTICLES
- Advertisment -

Most Popular